PMC:7161517 / 3366-3635
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T11 | 49-52 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T34 | 245-268 | Disease | denotes | cardiovascular diseases | http://purl.obolibrary.org/obo/MONDO_0004995 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T24 | 197-200 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T30 | 49-52 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
| T31 | 90-104 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T32 | 94-104 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T33 | 106-120 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
| T36 | 106-117 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T37 | 118-120 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
| T38 | 151-168 | Chemical | denotes | mineralocorticoid | http://purl.obolibrary.org/obo/CHEBI_25354 |
| T39 | 178-189 | Chemical | denotes | antagonists | http://purl.obolibrary.org/obo/CHEBI_48706 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T24 | 0-269 | Sentence | denotes | Because of the adverse cardiovascular effects of RAS upregulation, its inhibition through ACE inhibitors, angiotensin II receptor blockers (ARBs), and mineralocorticoid receptor antagonists (MRAs) has been critical for the management of various cardiovascular diseases. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T6 | 245-268 | Phenotype | denotes | cardiovascular diseases | http://purl.obolibrary.org/obo/HP_0001626 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T98 | 23-37 | UBERON:0004535 | denotes | cardiovascular |
| T99 | 94-104 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T100 | 106-120 | CHEBI:48432;CHEBI:48432;DG_37 | denotes | angiotensin II |
| T101 | 121-138 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
| T102 | 151-168 | CHEBI:25354;CHEBI:25354 | denotes | mineralocorticoid |
| T103 | 169-189 | CHEBI:48561;CHEBI:48561 | denotes | receptor antagonists |
| T104 | 245-259 | UBERON:0004535 | denotes | cardiovascular |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 112 | 90-93 | Gene | denotes | ACE | Gene:1636 |
| 113 | 151-177 | Gene | denotes | mineralocorticoid receptor | Gene:4306 |
| 147 | 245-268 | Disease | denotes | cardiovascular diseases | MESH:D002318 |